Generic drugs use: Brazil tops in Latin America

Brazil is currently the largest market for generic drugs in Latin America. And with the current scenario and positive future projections, it is likely to emerge amongst the most potential markets for generic drugs in the world.

Brazil, one of the major emerging powers of the world, is marking its presence in the generic drugs industry. Identifying the importance of the country in this significant domain, a leading market research firm, has come up with research report "Generic Drugs Market in Brazil" to provide an updated and detailed account of the Brazilian Generic drugs industry. It examines the chief reasons why all major generic players are heading to Brazil to manufacture and sell their drugs.

The generic drugs market in Brazil witnessed an explosive growth of 38.8% and was valued in excess of US$ 1 Billion in 2006. The market was driven by several factors such as a supporting political environment, lower cost and patent expirations of several blockbuster drugs such as Kamagra,Penegra,Edegra,Generic Levitra,Zenegra. The market is presently being dominated by domestic generic manufacturers. However, the presence of foreign firms in the market is increasing rapidly.

The growth of the market is expected to remain strong with generics expected to occupy 22.8% of the total market by 2011, enabling Brazil to become one of the largest generic markets in the world.